Investors
List of the current and past investors into TetraLogic Pharmaceuticals with their respective financial instruments.| Investor | Profile | Country | Phone | Round | |||
|---|---|---|---|---|---|---|---|
|
Amgen Inc | United States | +1 (805) 447-1000 | N/A | |||
|
Clarus Ventures II | Venture capital fund investing in biopharmaceuticals and medical technology | United States | Series C | |||
|
Hatteras Venture Partners III (HVP III) | United States | +1 (919) 484-0730 | Series C | |||
|
Healthcare Ventures LLC | Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. | United States | +1 (617) 252-4343 | Series B | ||
|
|
Healthcare Ventures LLC | Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. | United States | +1 (617) 252-4343 | Series C | ||
|
Latterell Venture Partners (LVP) | United States | +1 (415) 399-9880 | Series B | |||
|
|
Latterell Venture Partners (LVP) | United States | +1 (415) 399-9880 | Series C | |||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Nextech Invest Ltd (Nextech Venture) | Switzerland | +41 (1) 366-6611 | Series C | |||
|
Novitas Capital | United States | Series C | ||||
|
|
PA Early Stage Partners (Pennsylvania Early Stage Partners) | United States | Series B | ||||
|
Pfizer Inc | United States | +1 (212) 733-7034 | Series C | |||
|
Quaker BioVentures Inc | United States | +1 (215) 988-6800 | Series B | |||
|
|
Quaker BioVentures Inc | United States | +1 (215) 988-6800 | Series C | |||
|
The Vertical Group Inc | United States | +1 (650) 566-9060 | Series B | |||
|
|
The Vertical Group Inc | United States | +1 (650) 566-9060 | Series C |